EFFECT OF FSH TREATMENT ON ANEUPLOIDIC RATE IN OLIGOASTENOZOOSPERMIC PATIENTS - ND
- Conditions
- couple infertilityMedDRA version: 9.1Level: SOCClassification code 10038604Term: Reproductive system and breast disorders
- Registration Number
- EUCTR2007-005397-31-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
severe male factor
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
female: age > 38; reduced ovarian reserve; endometriosis
male: chromosomical and/or genic anomalies
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: decrease of aneuploidic rate by treatment;Secondary Objective: 1. increase of seminal parameters<br>2. increase of pregnancy rate;Primary end point(s): decrease of aneuploidic rate by treatment
- Secondary Outcome Measures
Name Time Method